
A study comparing cardiac risk stratification methods for emergency department patients with chest pain reveals that a new HEART pathway using high-sensitivity troponin improves acute myocardial infarction (AMI) detection by 1.8%. In a cohort of 17,384 patients, the high-sensitivity troponin group had higher AMI diagnoses (5.8% vs. 4.4%) without an increase in 30-day mortality. Additionally, resource utilization decreased, with fewer admissions (12.2% vs. 15.0%), stress tests (10.2% vs. 12.8%), and coronary revascularizations (1.0% vs. 2.0%) in the high-sensitivity troponin group. The findings suggest improved risk stratification and reduced resource use in chest pain patients.
Like
Save
Share